{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T06:27:35Z","timestamp":1791872855768,"version":"4.3.4"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2017,8,9]],"date-time":"2017-08-09T00:00:00Z","timestamp":1502236800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1007\/s00228-017-2316-1","type":"journal-article","created":{"date-parts":[[2017,8,9]],"date-time":"2017-08-09T10:21:49Z","timestamp":1502274109000},"page":"1491-1497","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["A retrospective study on the risk factors for bleeding events in warfarin therapy, focusing on renal function"],"prefix":"10.1007","volume":"73","author":[{"given":"Toshinori","family":"Hirai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukihiro","family":"Hamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujiro","family":"Geka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiori","family":"Kuwana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Hirai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai","family":"Ishibashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Fukaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshimi","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,8,9]]},"reference":[{"issue":"9526","key":"2316_CR1","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1016\/S0140-6736(06)68845-4","volume":"367","author":"S Connolly","year":"2006","unstructured":"Connolly S, Pogue J, Hart R, Pfeffer M, Hohnloser S, Chrolavicius S, Yusuf S (2006) Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events (ACTIVE W): a randomised controlled trial. Lancet 367(9526):1903\u20131912. doi:\n10.1016\/S0140-6736(06)68845-4","journal-title":"Lancet"},{"issue":"12","key":"2316_CR2","doi-asserted-by":"publisher","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","volume":"146","author":"RG Hart","year":"2007","unstructured":"Hart RG, Pearce LA, Aguilar MI (2007) Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 146(12):857\u2013867. doi:\n10.7326\/0003-4819-146-12-200706190-00007","journal-title":"Ann Intern Med"},{"issue":"11","key":"2316_CR3","doi-asserted-by":"publisher","first-page":"796","DOI":"10.7326\/0003-4819-157-10-201211200-00532","volume":"157","author":"SS Adam","year":"2012","unstructured":"Adam SS, McDuffie JR, Ortel TL, Williams JW Jr (2012) Comparative effectiveness of warfarin and new oral anticoagulants for the management of atrial fibrillation and venous thromboembolism: a systematic review. Ann Intern Med 157(11):796\u2013807. doi:\n10.7326\/0003-4819-157-10-201211200-00532","journal-title":"Ann Intern Med"},{"issue":"20","key":"2316_CR4","first-page":"1477","volume":"12","author":"G Teklay","year":"2014","unstructured":"Teklay G, Shiferaw N, Legesse B, Bekele ML (2014) Drug-drug interactions and risk of bleeding among inpatients on warfarin therapy: a prospective observational study. Thromb J 12(20):1477\u20139560","journal-title":"Thromb J"},{"issue":"6","key":"2316_CR5","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1161\/STROKEAHA.107.504993","volume":"39","author":"K Toyoda","year":"2008","unstructured":"Toyoda K, Yasaka M, Iwade K, Nagata K, Koretsune Y, Sakamoto T, Uchiyama S, Gotoh J, Nagao T, Yamamoto M, Takahashi JC, Minematsu K (2008) Dual antithrombotic therapy increases severe bleeding events in patients with stroke and cardiovascular disease: a prospective, multicenter, observational study. Stroke 39(6):1740\u20131745","journal-title":"Stroke"},{"issue":"9872","key":"2316_CR6","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/s0140-6736(12)62177-1","volume":"381","author":"WJ Dewilde","year":"2013","unstructured":"Dewilde WJ, Oirbans T, Verheugt FW, Kelder JC, De Smet BJ, Herrman JP, Adriaenssens T, Vrolix M, Heestermans AA, Vis MM, Tijsen JG, Van \u2018t Hof AW, ten Berg JM (2013) Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial. Lancet 381(9872):1107\u20131115. doi:\n10.1016\/s0140-6736(12)62177-1","journal-title":"Lancet"},{"issue":"8","key":"2316_CR7","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1097\/HJH.0b013e32833a7dfe","volume":"28","author":"T Horio","year":"2010","unstructured":"Horio T, Iwashima Y, Kamide K, Tokudome T, Yoshihara F, Nakamura S, Kawano Y (2010) Chronic kidney disease as an independent risk factor for new-onset atrial fibrillation in hypertensive patients. J Hypertens 28(8):1738\u20131744. doi:\n10.1097\/HJH.0b013e32833a7dfe","journal-title":"J Hypertens"},{"issue":"16","key":"2316_CR8","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1161\/circulationaha.112.113944","volume":"126","author":"BK Mahmoodi","year":"2012","unstructured":"Mahmoodi BK, Gansevoort RT, Naess IA, Lutsey PL, Braekkan SK, Veeger NJ, Brodin EE, Meijer K, Sang Y, Matsushita K, Hallan SI, Hammerstrom J, Cannegieter SC, Astor BC, Coresh J, Folsom AR, Hansen JB, Cushman M (2012) Association of mild to moderate chronic kidney disease with venous thromboembolism: pooled analysis of five prospective general population cohorts. Circulation 126(16):1964\u20131971. doi:\n10.1161\/circulationaha.112.113944","journal-title":"Circulation"},{"key":"2316_CR9","doi-asserted-by":"crossref","first-page":"h246","DOI":"10.1136\/bmj.h246","volume":"350","author":"M Jun","year":"2015","unstructured":"Jun M, James MT, Manns BJ, Quinn RR, Ravani P, Tonelli M, Perkovic V, Winkelmayer WC, Ma Z, Hemmelgarn BR (2015) The association between kidney function and major bleeding in older adults with atrial fibrillation starting warfarin treatment: population based observational study. BMJ 350:h246","journal-title":"BMJ"},{"issue":"11","key":"2316_CR10","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1161\/circulationaha.113.004777","volume":"129","author":"M Shah","year":"2014","unstructured":"Shah M, Avgil Tsadok M, Jackevicius CA, Essebag V, Eisenberg MJ, Rahme E, Humphries KH, Tu JV, Behlouli H, Guo H, Pilote L (2014) Warfarin use and the risk for stroke and bleeding in patients with atrial fibrillation undergoing dialysis. Circulation 129(11):1196\u20131203. doi:\n10.1161\/circulationaha.113.004777","journal-title":"Circulation"},{"issue":"6","key":"2316_CR11","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","volume":"53","author":"S Matsuo","year":"2009","unstructured":"Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A (2009) Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 53(6):982\u2013992. doi:\n10.1053\/j.ajkd.2008.12.034","journal-title":"Am J Kidney Dis"},{"issue":"10","key":"2316_CR12","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1093\/europace\/euv309","volume":"17","author":"H Heidbuchel","year":"2015","unstructured":"Heidbuchel H, Verhamme P, Alings M, Antz M, Diener HC, Hacke W, Oldgren J, Sinnaeve P, Camm AJ, Kirchhof P (2015) Updated European heart rhythm association practical guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation. Europace 17(10):1467\u20131507. doi:\n10.1093\/europace\/euv309","journal-title":"Europace"},{"issue":"2","key":"2316_CR13","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1248\/bpb.b12-00584","volume":"36","author":"M Tanaka","year":"2013","unstructured":"Tanaka M, Tanaka A, Suemaru K, Araki H (2013) The assessment of risk for gastrointestinal injury with anticoagulant and antiplatelet drugs: the possible beneficial effect of eicosapentaenoic acid for the risk of gastrointestinal injury. Biol Pharm Bull 36(2):222\u2013227","journal-title":"Biol Pharm Bull"},{"issue":"8","key":"2316_CR14","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1111\/j.1532-5415.2006.00828.x","volume":"54","author":"MC Fang","year":"2006","unstructured":"Fang MC, Go AS, Hylek EM, Chang Y, Henault LE, Jensvold NG, Singer DE (2006) Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study. J Am Geriatr Soc 54(8):1231\u20131236. doi:\n10.1111\/j.1532-5415.2006.00828.x","journal-title":"J Am Geriatr Soc"},{"issue":"5","key":"2316_CR15","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1111\/j.1365-2125.2012.04259.x","volume":"74","author":"BP Jensen","year":"2012","unstructured":"Jensen BP, Chin PK, Roberts RL, Begg EJ (2012) Influence of adult age on the total and free clearance and protein binding of (R)- and (S)-warfarin. Br J Clin Pharmacol 74(5):797\u2013805. doi:\n10.1111\/j.1365-2125.2012.04259.x","journal-title":"Br J Clin Pharmacol"},{"issue":"12","key":"2316_CR16","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1007\/s00228-007-0381-6","volume":"63","author":"L Miao","year":"2007","unstructured":"Miao L, Yang J, Huang C, Shen Z (2007) Contribution of age, body weight, and CYP2C9 and VKORC1 genotype to the anticoagulant response to warfarin: proposal for a new dosing regimen in Chinese patients. Eur J Clin Pharmacol 63(12):1135\u20131141. doi:\n10.1007\/s00228-007-0381-6","journal-title":"Eur J Clin Pharmacol"},{"issue":"2","key":"2316_CR17","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.amjmed.2016.08.017","volume":"130","author":"R Hart","year":"2017","unstructured":"Hart R, Veenstra DL, Boudreau DM, Roth JA (2017) Impact of body mass index and genetics on warfarin major bleeding outcomes in a community setting. Am J Med 130(2):222\u2013228. doi:\n10.1016\/j.amjmed.2016.08.017","journal-title":"Am J Med"},{"issue":"2","key":"2316_CR18","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1161\/strokeaha.115.011876","volume":"47","author":"K Senoo","year":"2016","unstructured":"Senoo K, Lip GY (2016) Body mass index and adverse outcomes in elderly patients with atrial fibrillation: the AMADEUS trial. Stroke 47(2):523\u2013526. doi:\n10.1161\/strokeaha.115.011876","journal-title":"Stroke"},{"issue":"5","key":"2316_CR19","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1378\/chest.10-0134","volume":"138","author":"R Pisters","year":"2010","unstructured":"Pisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns HJ, Lip GY (2010) A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the euro heart survey. Chest 138(5):1093\u20131100. doi:\n10.1378\/chest.10-0134","journal-title":"Chest"},{"issue":"3","key":"2316_CR20","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.jjcc.2014.08.008","volume":"65","author":"N Ichihara","year":"2015","unstructured":"Ichihara N, Ishigami T, Umemura S (2015) Effect of impaired renal function on the maintenance dose of warfarin in Japanese patients. J Cardiol 65(3):178\u2013184. doi:\n10.1016\/j.jjcc.2014.08.008","journal-title":"J Cardiol"},{"issue":"11","key":"2316_CR21","doi-asserted-by":"publisher","first-page":"e27808","DOI":"10.1371\/journal.pone.0027808","volume":"6","author":"IY Gong","year":"2011","unstructured":"Gong IY, Schwarz UI, Crown N, Dresser GK, Lazo-Langner A, Zou G, Roden DM, Stein CM, Rodger M, Wells PS, Kim RB, Tirona RG (2011) Clinical and genetic determinants of warfarin pharmacokinetics and pharmacodynamics during treatment initiation. PLoS One 6(11):e27808. doi:\n10.1371\/journal.pone.0027808","journal-title":"PLoS One"},{"issue":"6","key":"2316_CR22","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.thromres.2013.01.006","volume":"131","author":"M Wieloch","year":"2013","unstructured":"Wieloch M, Jonsson KM, Sjalander A, Lip GY, Eriksson N, Svensson PJ (2013) Estimated glomerular filtration rate is associated with major bleeding complications but not thromboembolic events, in anticoagulated patients taking warfarin. Thromb Res 131(6):481\u2013486. doi:\n10.1016\/j.thromres.2013.01.006","journal-title":"Thromb Res"},{"issue":"24","key":"2316_CR23","doi-asserted-by":"publisher","first-page":"2689","DOI":"10.1016\/j.jacc.2014.03.039","volume":"63","author":"M Lamberts","year":"2014","unstructured":"Lamberts M, Lip GY, Ruwald MH, Hansen ML, Ozcan C, Kristensen SL, Kober L, Torp-Pedersen C, Gislason GH (2014) Antithrombotic treatment in patients with heart failure and associated atrial fibrillation and vascular disease: a nationwide cohort study. J Am Coll Cardiol 63(24):2689\u20132698. doi:\n10.1016\/j.jacc.2014.03.039","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"2316_CR24","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s00228-011-1123-3","volume":"68","author":"MA Rasmussen","year":"2012","unstructured":"Rasmussen MA, Skov J, Bladbjerg EM, Sidelmann JJ, Vamosi M, Jespersen J (2012) Multivariate analysis of the relation between diet and warfarin dose. Eur J Clin Pharmacol 68(3):321\u2013328. doi:\n10.1007\/s00228-011-1123-3","journal-title":"Eur J Clin Pharmacol"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-017-2316-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-017-2316-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-017-2316-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,10,30]],"date-time":"2017-10-30T04:52:54Z","timestamp":1509339174000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-017-2316-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,9]]},"references-count":24,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["2316"],"URL":"https:\/\/doi.org\/10.1007\/s00228-017-2316-1","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,9]]}}}